There are 717 resources available
State-of-the-art management of metastatic hormone-sensitive prostate cancer (mHSPC)
Presenter: Karim Fizazi
Session: Optimal treatment of prostate cancer in changing times
Resources:
Slides
Webcast
Metastatic castration-resistant prostate (mCRPC) cancer updates
Presenter: Silke Gillessen
Session: Optimal treatment of prostate cancer in changing times
Resources:
Slides
Webcast
How ESMO successfully advocated towards protecting health research at the EU level: The General Data Protection Regulation (GDPR) story
Presenter: Paolo G. Casali
Session: Cancer policy in the Asia-Pacific region: How to successfully advocate for access to care and research
Resources:
Slides
Webcast
Access to high quality and sustainable care in the Asia-Pacific region: The perspective of HTA
Presenter: Lydia Loke
Session: Cancer policy in the Asia-Pacific region: How to successfully advocate for access to care and research
Resources:
Slides
Webcast
Neoadjuvant immunotherapy: Why does it work better?
Presenter: John Haanen
Session: What are the most exciting new developments in immunotherapy of cancer?
Resources:
Slides
Webcast
CAR-T in solid cancer: What are the hurdles?
Presenter: Shigehisa Kitano
Session: What are the most exciting new developments in immunotherapy of cancer?
Resources:
Slides
Webcast
Combining immunotherapy and angiogenesis inhibition: Is there synergy?
Presenter: Solange Peters
Session: What are the most exciting new developments in immunotherapy of cancer?
Resources:
Slides
Webcast
Intratumoral immunotherapy: For whom?
Presenter: Jonathan Cebon
Session: What are the most exciting new developments in immunotherapy of cancer?
Resources:
Slides
Webcast
Mutational signatures: Predictive value across tumor types
Presenter: Xueqing Zou
Session: Precision oncology: Genomics and beyond
Resources:
Slides
Webcast
Translating cancer evolution into clinical management
Presenter: Hiroya Taniguchi
Session: Precision oncology: Genomics and beyond
Resources:
Slides
Webcast